Literature DB >> 8242836

Complement-dependent phagocytosis of liposomes.

N M Wassef1, C R Alving.   

Abstract

In this article we describe an in vitro model for complement-dependent phagocytosis of liposomes. We have previously reported that complement-opsonized liposomes are avidly ingested by murine peritoneal or bone marrow-derived cultured macrophages. However, when the liposomes contained certain lipids, including phosphatidylinositol, ganglioside GM1, and sulfogalactosyl ceramide, that have been identified as causing prolonged circulation time in vivo, complement-dependent phagocytosis of the liposomes was greatly suppressed. We identify certain additional factors associated with suppressed complement-dependent phagocytosis, including, liposomal negative charge and liposomal prostaglandin E2 or thromboxane B2. Possible mechanisms responsible for suppression of complement dependent phagocytosis are suggested. We propose that suppression of complement-dependent phagocytosis could be a contributing factor in the promotion of increased circulation time of 'stealth' liposomes and that complement opsonization probably plays a role in vivo in removing liposomes from the circulation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8242836     DOI: 10.1016/0009-3084(93)90068-e

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  4 in total

1.  CDP-choline liposomes provide significant reduction in infarction over free CDP-choline in stroke.

Authors:  Rao Muralikrishna Adibhatla; J F Hatcher; K Tureyen
Journal:  Brain Res       Date:  2005-10-05       Impact factor: 3.252

2.  Phosphatidylinositol induces fluid phase formation and packing defects in phosphatidylcholine model membranes.

Authors:  Aaron Peng; Dipak S Pisal; Amy Doty; Sathy V Balu-Iyer
Journal:  Chem Phys Lipids       Date:  2011-10-17       Impact factor: 3.329

Review 3.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Authors:  Phatsapong Yingchoncharoen; Danuta S Kalinowski; Des R Richardson
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

4.  Discrepancy of contrast-enhanced ultrasonographic pattern with two contrast agents in steatohepatitic subtype hepatocellular carcinoma: A case report.

Authors:  Jiang Bo; Kong BeiNing; Fei Xiang; Wan XinKun; Luo YuKun
Journal:  Radiol Case Rep       Date:  2022-04-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.